Effects of Dose and Injection Site for Gummy Smile Treatment With Botulinum Type A

计划入组 55 人 · 首次发布于 2021 年 3 月 29 日

ESICM UNITE COVID-19 Project (UNITE-COVID)

计划入组 4,995 人 · 首次发布于 2021 年 4 月 8 日

Clinical Trial NuSmile Crowns

计划入组 97 人 · 首次发布于 2021 年 7 月 23 日

cell cycle (a) (uSMITE, breast/pancreatic/lung cancer/malignant melanoma)

Copper usnate

C₁₈H₁₄CuO₇

SMTE-001

NuSMILE, LTD.

United States

UNITE 11

France

SMITH, MARIANNE

United States

Pulmatrix to Divest Phase 2-Ready Migraine Treatment and iSPERSE Technology Ahead of Cullgen Merger

Cullgen Launches Phase 1 Trial of Novel Non-Opioid Pain Treatment Using Protein Degradation Technology

IQVIA Launches AI-Powered Clinical Trial Financial Suite to Automate Site Payments and Budget Management